No actionable change from this filing. Guidance is unchanged — earnings risk remains on execution of existing forecasts. Monitor Pfizer's Q2 2026 earnings for any revision to FY2026 guidance or updates on the CFO search.
Price Chart
Executive Summary
Pfizer reaffirms full-year 2026 guidance following the CFO transition announcement on June 18, 2026. Revenue guidance remains $59.5-$62.5B and adjusted diluted EPS at $2.80-$3.00, unchanged from prior communication. This is a routine confirmation filing with no new material financial data.
Key Facts
- FY2026 revenue guidance reaffirmed at $59.5-$62.5B
- FY2026 adjusted diluted EPS guidance reaffirmed at $2.80-$3.00
- CFO transition announced on June 18, 2026, prompted this reaffirmation
Financial Impact
No new financial data; previously guided revenue and EPS ranges unchanged.
Risk Factors
- Future earnings miss could pressure stock if revenue or EPS fall below guided ranges
- CFO transition adds management uncertainty, potentially affecting execution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000078003-26-000087 |
| Document: 0000078003-26-000087-index-headers.html | 0000078003-26-000087 |
| Document: 0000078003-26-000087-index.html | 0000078003-26-000087 |
| Document: 0000078003-26-000087.txt | 0000078003-26-000087 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | Court Ruling | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 12, 2026 7w ago | Insider Buy | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 12, 2026 7w ago | Insider Cluster | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.55 (+5.13%) |
Aug 5, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.55 (+5.13%) |
Aug 4, 2026 8w ago | 8-K | $25.41 $28.55 | ▲ +12.36% | ▲ +13.60% | $27.55 (+8.40%) |
Jul 31, 2026 9w ago | Court Ruling | $25.01 $27.96 | ▼ −11.80% | ▼ −8.81% | $27.55 (−10.14%) |
Jul 24, 2026 10w ago | Court Ruling | $24.54 $28.07 | ▲ +14.38% | ▲ +10.76% | $27.55 (+12.25%) |
Jul 6, 2026 12w ago | ANALYST-DOWNGRADE | $23.72 $25.01 | ▼ −5.44% | ▼ −6.00% | $27.55 (−16.13%) |
Jun 18, 2026 15w ago | 8-K | $25.21 $25.14 | ▼ −0.28% | ▼ −0.81% | $27.55 (+9.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access